Animal Models & Clinical Trials

The development of human vaccines continues to rely on the use of animals for research. Regulatory authorities require novel vaccine candidates to undergo preclinical assessment in animal models before being permitted to enter the clinical phase in human subjects. Substantial progress has been made in recent years in reducing and replacing the number of animals used for preclinical vaccine research through the use of bioinformatics and computational biology to design new vaccine candidates. However, the ultimate goal of a new vaccine is to instruct the immune system to elicit an effective immune response against the pathogen of interest, and no alternatives to live animal use currently exist for evaluation of this response.


    Related Conference of Animal Models & Clinical Trials

    July 15-16, 2024

    38th International Conference on Immunology

    Toronto, Canada

    Animal Models & Clinical Trials Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in